只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-05-14 2026-05-15 | NSPR InspireMD, Inc. | Stuka Paul Director | 买入（P） | 5,000 | US$1.15 | US$5,750.00 | 647,871 | SEC |
| 2026-05-13 2026-05-15 | NSPR InspireMD, Inc. | Stuka Paul Director | 买入（P） | 10,000 | US$1.16 | US$11,600.00 | 642,871 | SEC |
| 2026-05-12 2026-05-13 | NSPR InspireMD, Inc. | Slosman Marvin Director,Officer · CEO and President | 买入（P） | 21,000 | US$1.20 | US$25,200.00 | 3,556,658 | SEC |
| 2026-05-11 2026-05-13 | NSPR InspireMD, Inc. | Stuka Paul Director | 买入（P） | 10,000 | US$1.19 | US$11,900.00 | 632,871 | SEC |
| 2026-05-11 2026-05-12 | NSPR InspireMD, Inc. | Stuka Paul Director | 买入（P） | 10,000 | US$1.19 | US$11,900.00 | 632,871 | SEC |
| 2026-05-08 2026-05-13 | NSPR InspireMD, Inc. | Stuka Paul Director | 买入（P） | 65,626 | US$1.16 | US$76,126.16 | 622,871 | SEC |
| 2026-05-08 2026-05-12 | NSPR InspireMD, Inc. | Stuka Paul Director | 买入（P） | 65,626 | US$1.16 | US$76,126.16 | 622,871 | SEC |
| 2026-05-07 2026-05-08 | NSPR InspireMD, Inc. | ROUBIN GARY S Director | 买入（P） | 90,000 | US$1.18 | US$106,200.00 | 834,478 | SEC |
| 2026-05-07 2026-05-08 | NSPR InspireMD, Inc. | Stuka Paul Director | 买入（P） | 6,378 | US$1.15 | US$7,334.70 | 531,599 | SEC |
| 2026-05-07 2026-05-08 | NSPR InspireMD, Inc. | Ward Scott R. Director | 买入（P） | 73,255 | US$1.15 | US$84,243.25 | 237,096 | SEC |
| 2026-05-06 2026-05-08 | NSPR InspireMD, Inc. | Stuka Paul Director | 买入（P） | 1,517 | US$1.12 | US$1,699.04 | 525,221 | SEC |
| 2026-05-06 2026-05-08 | NSPR InspireMD, Inc. | Ward Scott R. Director | 买入（P） | 15,995 | US$1.15 | US$18,394.25 | 163,841 | SEC |
| 2026-02-02 2026-05-21 | NSPR InspireMD, Inc. | Gleason Shane Thomas Officer · Chief Commercial Officer | 卖出（S） | 2,941 | US$1.59 | US$4,676.19 | 1,076,660 | SEC |
| 2025-05-30 2026-05-21 | NSPR InspireMD, Inc. | Gleason Shane Thomas Officer · Chief Commercial Officer | 卖出（S） | 7,186 | US$2.51 | US$18,036.86 | 1,079,601 | SEC |
| 2025-05-29 2026-05-21 | NSPR InspireMD, Inc. | Gleason Shane Thomas Officer · Chief Commercial Officer | 卖出（S） | 3,760 | US$2.51 | US$9,437.60 | 1,086,787 | SEC |
| 2025-05-27 2026-05-21 | NSPR InspireMD, Inc. | Gleason Shane Thomas Officer · Chief Commercial Officer | 卖出（S） | 1,572 | US$2.51 | US$3,945.72 | 1,090,547 | SEC |
| 2025-05-23 2026-05-21 | NSPR InspireMD, Inc. | Gleason Shane Thomas Officer · Chief Commercial Officer | 卖出（S） | 2,482 | US$2.51 | US$6,229.82 | 1,092,119 | SEC |
| 2025-02-25 2026-05-21 | NSPR InspireMD, Inc. | Gleason Shane Thomas Officer · Chief Commercial Officer | 卖出（S） | 10,000 | US$3.65 | US$36,500.00 | 1,094,601 | SEC |
| 2025-02-04 2026-05-21 | NSPR InspireMD, Inc. | Gleason Shane Thomas Officer · Chief Commercial Officer | 卖出（S） | 5,132 | US$2.46 | US$12,624.72 | 1,104,601 | SEC |
| 2025-02-03 2026-05-21 | NSPR InspireMD, Inc. | Gleason Shane Thomas Officer · Chief Commercial Officer | 卖出（S） | 7,073 | US$2.51 | US$17,753.23 | 1,109,733 | SEC |
| 2025-01-31 2026-05-21 | NSPR InspireMD, Inc. | Gleason Shane Thomas Officer · Chief Commercial Officer | 卖出（S） | 9,923 | US$2.55 | US$25,303.65 | 1,116,806 | SEC |
| 2025-01-30 2026-05-21 | NSPR InspireMD, Inc. | Gleason Shane Thomas Officer · Chief Commercial Officer | 卖出（S） | 2,454 | US$2.51 | US$6,159.54 | 1,126,729 | SEC |
| 2025-01-29 2026-05-21 | NSPR InspireMD, Inc. | Gleason Shane Thomas Officer · Chief Commercial Officer | 卖出（S） | 3,660 | US$2.46 | US$9,003.60 | 1,129,183 | SEC |
| 2025-01-28 2026-05-21 | NSPR InspireMD, Inc. | Gleason Shane Thomas Officer · Chief Commercial Officer | 卖出（S） | 2,476 | US$2.61 | US$6,462.36 | 1,132,843 | SEC |
| 2025-01-27 2026-05-21 | NSPR InspireMD, Inc. | Gleason Shane Thomas Officer · Chief Commercial Officer | 卖出（S） | 3,858 | US$2.71 | US$10,455.18 | 1,135,319 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| NSPR | 8,673 | 0 | 45,722.9006 | 18.97% | Q |